Target intelligence / Profile preview

Novel transcript, antisense to HCK

Molecular classification: lncRNA

Overview

This molecule is a long non-coding RNA (lncRNA) denoted as a "novel transcript, antisense to HCK," represented by the Ensembl identifier ENSG00000306166. It is not a protein-coding gene and is classified as a non-coding RNA, meaning it does not encode a conventional therapeutic target such as a receptor, enzyme, transporter, or ion channel. There is no available information regarding its biological function, disease association, interacting drugs, or clinical relevance[1].

Beyond the preview

Go deeper on Novel transcript, antisense to HCK.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to HCK.

Explore the full profile